Salient to Investors:
Since 2008, at least 94 of the 400 people sued by regulators or charged with insider trading passed or received tips involving pharmaceutical, biotech or other health-care stocks.
Read the full article at http://www.bloomberg.com/news/2012-11-27/harvard-doctor-turns-felon-after-lure-of-insider-trading.html